Trial intelligence / Profile preview

Flutiform vs Symbicort in moderate to severe asthma

NCT01099722Phase 3Completed

Sponsor
Mundipharma
Start
Apr 2010
Primary completion
Nov 2010
Modality
Orthosteric Ligands
Countries
5
01

Overview

A Phase 3 trial of fluticasone propionate + formoterol in asthma, sponsored by Mundipharma. Started Apr 2010; status: completed.

02

Drugs

fluticasone propionate + formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01099722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01099722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call